APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceuticals Plant Protein

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmaceuticals Plant Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17347850032 January 2026197 pages

Choose your research edition.

Industry ResearchPharmaceuticals Plant Protein Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceuticals Plant Protein Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Pharmaceuticals Plant Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceuticals Plant Protein Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceuticals Plant Protein Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pharmaceuticals Plant Protein market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pharmaceuticals Plant Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceuticals Plant Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceuticals Plant Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmaceuticals Plant Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceuticals Plant Protein include ADM, Cargill, DuPont, Kerry Group, Manildra, Roquette, Tereos, Axiom Foods and Cosucra, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharmaceuticals Plant Protein market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceuticals Plant Protein and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceuticals Plant Protein sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceuticals Plant Protein market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceuticals Plant Protein Segment by Company

ADM

Cargill

DuPont

Kerry Group

Manildra

Roquette

Tereos

Axiom Foods

Cosucra

CHS

Glanbia Nutritionals

Pharmaceuticals Plant Protein Segment by Type

Soy Protein

Wheat Protein

Pea Protein

Others

Pharmaceuticals Plant Protein Segment by Application

Dietary Supplements

Medicinal Protein

Others

Pharmaceuticals Plant Protein Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceuticals Plant Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceuticals Plant Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceuticals Plant Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceuticals Plant Protein market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharmaceuticals Plant Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pharmaceuticals Plant Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pharmaceuticals Plant Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pharmaceuticals Plant Protein Industry Trends Table 2. Pharmaceuticals Plant Protein Industry Drivers Table 3. Pharmaceuticals Plant Protein Industry Opportunities and Challenges Table 4. Pharmaceuticals Plant Protein Industry Restraints Table 5. Global Pharmaceuticals Plant Protein Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pharmaceuticals Plant Protein Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pharmaceuticals Plant Protein Sales by Manufacturers (kt) & (2021-2026) Table 8. Global Pharmaceuticals Plant Protein Sales Market Share by Manufacturers Table 9. Global Pharmaceuticals Plant Protein Average Sales Price (USD/t) of Manufacturers (2021-2026) Table 10. Global Pharmaceuticals Plant Protein Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pharmaceuticals Plant Protein Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pharmaceuticals Plant Protein Manufacturers, Product Type & Application Table 13. Global Pharmaceuticals Plant Protein Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceuticals Plant Protein by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Soy Protein Table 17. Major Manufacturers of Wheat Protein Table 18. Major Manufacturers of Pea Protein Table 19. Major Manufacturers of Others Table 20. Global Pharmaceuticals Plant Protein Sales by Type 2021 VS 2025 VS 2032 (kt) Table 21. Global Pharmaceuticals Plant Protein Sales by Type (2021-2026) & (kt) Table 22. Global Pharmaceuticals Plant Protein Sales by Type (2027-2032) & (kt) Table 23. Global Pharmaceuticals Plant Protein Sales Market Share by Type (2021-2026) Table 24. Global Pharmaceuticals Plant Protein Sales Market Share by Type (2027-2032) Table 25. Global Pharmaceuticals Plant Protein Revenue by Type 2021 VS 2025 VS 2032 (kt) Table 26. Global Pharmaceuticals Plant Protein Revenue by Type (2021-2026) & (kt) Table 27. Global Pharmaceuticals Plant Protein Revenue by Type (2027-2032) & (kt) Table 28. Global Pharmaceuticals Plant Protein Revenue Market Share by Type (2021-2026) Table 29. Global Pharmaceuticals Plant Protein Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Dietary Supplements Table 31. Major Manufacturers of Medicinal Protein Table 32. Major Manufacturers of Others Table 33. Global Pharmaceuticals Plant Protein Sales by Application 2021 VS 2025 VS 2032 (kt) Table 34. Global Pharmaceuticals Plant Protein Sales by Application (2021-2026) & (kt) Table 35. Global Pharmaceuticals Plant Protein Sales by Application (2027-2032) & (kt) Table 36. Global Pharmaceuticals Plant Protein Sales Market Share by Application (2021-2026) Table 37. Global Pharmaceuticals Plant Protein Sales Market Share by Application (2027-2032) Table 38. Global Pharmaceuticals Plant Protein Revenue by Application 2021 VS 2025 VS 2032 (kt) Table 39. Global Pharmaceuticals Plant Protein Revenue by Application (2021-2026) & (kt) Table 40. Global Pharmaceuticals Plant Protein Revenue by Application (2027-2032) & (kt) Table 41. Global Pharmaceuticals Plant Protein Revenue Market Share by Application (2021-2026) Table 42. Global Pharmaceuticals Plant Protein Revenue Market Share by Application (2027-2032) Table 43. Global Pharmaceuticals Plant Protein Sales by Region: 2021 VS 2025 VS 2032 (kt) Table 44. Global Pharmaceuticals Plant Protein Sales by Region (2021-2026) & (kt) Table 45. Global Pharmaceuticals Plant Protein Sales Market Share by Region (2021-2026) Table 46. Global Pharmaceuticals Plant Protein Sales Forecasted by Region (2027-2032) & (kt) Table 47. Global Pharmaceuticals Plant Protein Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Pharmaceuticals Plant Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 49. North America Pharmaceuticals Plant Protein Sales by Country (2021-2026) & (kt) Table 50. North America Pharmaceuticals Plant Protein Sales by Country (2027-2032) & (kt) Table 51. Europe Pharmaceuticals Plant Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 52. Europe Pharmaceuticals Plant Protein Sales by Country (2021-2026) & (kt) Table 53. Europe Pharmaceuticals Plant Protein Sales by Country (2027-2032) & (kt) Table 54. Asia Pacific Pharmaceuticals Plant Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 55. Asia Pacific Pharmaceuticals Plant Protein Sales by Country (2021-2026) & (kt) Table 56. Asia Pacific Pharmaceuticals Plant Protein Sales by Country (2027-2032) & (kt) Table 57. South America, Middle East and Africa Pharmaceuticals Plant Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kt) Table 58. South America, Middle East and Africa Pharmaceuticals Plant Protein Sales by Country (2021-2026) & (kt) Table 59. South America, Middle East and Africa Pharmaceuticals Plant Protein Sales by Country (2027-2032) & (kt) Table 60. Global Pharmaceuticals Plant Protein Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Pharmaceuticals Plant Protein Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Pharmaceuticals Plant Protein Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Pharmaceuticals Plant Protein Revenue Market Share by Region (2021-2026) Table 64. Global Pharmaceuticals Plant Protein Revenue Market Share by Region (2027-2032) Table 65. ADM Company Information Table 66. ADM Business Overview Table 67. ADM Pharmaceuticals Plant Protein Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. ADM Pharmaceuticals Plant Protein Product Portfolio Table 69. ADM Recent Development Table 70. Cargill Company Information Table 71. Cargill Business Overview Table 72. Cargill Pharmaceuticals Plant Protein Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Cargill Pharmaceuticals Plant Protein Product Portfolio Table 74. Cargill Recent Development Table 75. DuPont Company Information Table 76. DuPont Business Overview Table 77. DuPont Pharmaceuticals Plant Protein Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. DuPont Pharmaceuticals Plant Protein Product Portfolio Table 79. DuPont Recent Development Table 80. Kerry Group Company Information Table 81. Kerry Group Business Overview Table 82. Kerry Group Pharmaceuticals Plant Protein Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Kerry Group Pharmaceuticals Plant Protein Product Portfolio Table 84. Kerry Group Recent Development Table 85. Manildra Company Information Table 86. Manildra Business Overview Table 87. Manildra Pharmaceuticals Plant Protein Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Manildra Pharmaceuticals Plant Protein Product Portfolio Table 89. Manildra Recent Development Table 90. Roquette Company Information Table 91. Roquette Business Overview Table 92. Roquette Pharmaceuticals Plant Protein Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Roquette Pharmaceuticals Plant Protein Product Portfolio Table 94. Roquette Recent Development Table 95. Tereos Company Information Table 96. Tereos Business Overview Table 97. Tereos Pharmaceuticals Plant Protein Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Tereos Pharmaceuticals Plant Protein Product Portfolio Table 99. Tereos Recent Development Table 100. Axiom Foods Company Information Table 101. Axiom Foods Business Overview Table 102. Axiom Foods Pharmaceuticals Plant Protein Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Axiom Foods Pharmaceuticals Plant Protein Product Portfolio Table 104. Axiom Foods Recent Development Table 105. Cosucra Company Information Table 106. Cosucra Business Overview Table 107. Cosucra Pharmaceuticals Plant Protein Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Cosucra Pharmaceuticals Plant Protein Product Portfolio Table 109. Cosucra Recent Development Table 110. CHS Company Information Table 111. CHS Business Overview Table 112. CHS Pharmaceuticals Plant Protein Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. CHS Pharmaceuticals Plant Protein Product Portfolio Table 114. CHS Recent Development Table 115. Glanbia Nutritionals Company Information Table 116. Glanbia Nutritionals Business Overview Table 117. Glanbia Nutritionals Pharmaceuticals Plant Protein Sales (kt), Price (USD/t), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Glanbia Nutritionals Pharmaceuticals Plant Protein Product Portfolio Table 119. Glanbia Nutritionals Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Pharmaceuticals Plant Protein Distributors List Table 123. Pharmaceuticals Plant Protein Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Pharmaceuticals Plant Protein Product Image Figure 2. Global Pharmaceuticals Plant Protein Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceuticals Plant Protein Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceuticals Plant Protein Sales (2021-2032) & (kt) Figure 5. Global Pharmaceuticals Plant Protein Average Price (USD/t) & (2021-2032) Figure 6. Global Top 5 and 10 Pharmaceuticals Plant Protein Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Soy Protein Image Figure 9. Wheat Protein Image Figure 10. Pea Protein Image Figure 11. Others Image Figure 12. Global Pharmaceuticals Plant Protein Sales by Type (2021 VS 2025 VS 2032) & (kt) Figure 13. Global Pharmaceuticals Plant Protein Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Pharmaceuticals Plant Protein Sales Market Share by Type (2021-2032) Figure 15. Global Pharmaceuticals Plant Protein Revenue by Type (2021 VS 2025 VS 2032) & (kt) Figure 16. Global Pharmaceuticals Plant Protein Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Pharmaceuticals Plant Protein Revenue Market Share by Type (2021-2032) Figure 18. Dietary Supplements Image Figure 19. Medicinal Protein Image Figure 20. Others Image Figure 21. Global Pharmaceuticals Plant Protein Sales by Application (2021 VS 2025 VS 2032) & (kt) Figure 22. Global Pharmaceuticals Plant Protein Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Pharmaceuticals Plant Protein Sales Market Share by Application (2021-2032) Figure 24. Global Pharmaceuticals Plant Protein Revenue by Application (2021 VS 2025 VS 2032) & (kt) Figure 25. Global Pharmaceuticals Plant Protein Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Pharmaceuticals Plant Protein Revenue Market Share by Application (2021-2032) Figure 27. North America Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 28. North America Pharmaceuticals Plant Protein Sales Market Share by Country (2021-2032) Figure 29. U.S. Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 30. Canada Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 31. Mexico Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 32. Europe Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 33. Europe Pharmaceuticals Plant Protein Sales Market Share by Country (2021-2032) Figure 34. Germany Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 35. France Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 36. U.K. Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 37. Italy Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 38. Netherlands Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 39. Asia Pacific Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 40. Asia Pacific Pharmaceuticals Plant Protein Sales Market Share by Country (2021-2032) Figure 41. China Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 42. Japan Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 43. South Korea Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 44. Southeast Asia Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 45. India Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 46. Australia Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 47. South America, Middle East and Africa Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 48. South America, Middle East and Africa Pharmaceuticals Plant Protein Sales Market Share by Country (2021-2032) Figure 49. Brazil Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 50. South Africa Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 51. Saudi Arabia Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 52. Turkey Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 53. Argentina Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 54. UAE Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 55. Egypt Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 56. Chile Pharmaceuticals Plant Protein Sales and Growth Rate (2021-2032) & (kt) Figure 57. Global Pharmaceuticals Plant Protein Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Pharmaceuticals Plant Protein Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Pharmaceuticals Plant Protein Revenue (2021-2032) & (US$ Million) Figure 60. North America Pharmaceuticals Plant Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Pharmaceuticals Plant Protein Revenue (2021-2032) & (US$ Million) Figure 62. Europe Pharmaceuticals Plant Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Pharmaceuticals Plant Protein Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Pharmaceuticals Plant Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Pharmaceuticals Plant Protein Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Pharmaceuticals Plant Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Pharmaceuticals Plant Protein Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Pharmaceuticals Plant Protein Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Soy Protein
  • Wheat Protein
  • Pea Protein
  • Others
Applications
  • Dietary Supplements
  • Medicinal Protein
  • Others
Companies covered
  • ADM
  • Cargill
  • DuPont
  • Kerry Group
  • Manildra
  • Roquette
  • Tereos
  • Axiom Foods
  • Cosucra
  • CHS
  • Glanbia Nutritionals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceuticals Plant Protein Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceuticals Plant Protein Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pharmaceuticals Plant Protein Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pharmaceuticals Plant Protein Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pharmaceuticals Plant Protein Market Dynamics
  1. 2.1 Pharmaceuticals Plant Protein Industry Trends
  2. 2.2 Pharmaceuticals Plant Protein Industry Drivers
  3. 2.3 Pharmaceuticals Plant Protein Industry Opportunities and Challenges
  4. 2.4 Pharmaceuticals Plant Protein Industry Restraints
3 Pharmaceuticals Plant Protein Market by Manufacturers
  1. 3.1 Global Pharmaceuticals Plant Protein Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pharmaceuticals Plant Protein Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pharmaceuticals Plant Protein Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pharmaceuticals Plant Protein Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharmaceuticals Plant Protein Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pharmaceuticals Plant Protein Manufacturers, Product Type & Application
  7. 3.7 Global Pharmaceuticals Plant Protein Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharmaceuticals Plant Protein Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharmaceuticals Plant Protein Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pharmaceuticals Plant Protein Tier 1, Tier 2, and Tier 3
4 Pharmaceuticals Plant Protein Market by Type
  1. 4.1 Pharmaceuticals Plant Protein Type Introduction
  2. 4.1.1 Soy Protein
  3. 4.1.2 Wheat Protein
  4. 4.1.3 Pea Protein
  5. 4.1.4 Others
  6. 4.2 Global Pharmaceuticals Plant Protein Sales by Type
  7. 4.2.1 Global Pharmaceuticals Plant Protein Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharmaceuticals Plant Protein Sales by Type (2021-2032)
  9. 4.2.3 Global Pharmaceuticals Plant Protein Sales Market Share by Type (2021-2032)
  10. 4.3 Global Pharmaceuticals Plant Protein Revenue by Type
  11. 4.3.1 Global Pharmaceuticals Plant Protein Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pharmaceuticals Plant Protein Revenue by Type (2021-2032)
  13. 4.3.3 Global Pharmaceuticals Plant Protein Revenue Market Share by Type (2021-2032)
5 Pharmaceuticals Plant Protein Market by Application
  1. 5.1 Pharmaceuticals Plant Protein Application Introduction
  2. 5.1.1 Dietary Supplements
  3. 5.1.2 Medicinal Protein
  4. 5.1.3 Others
  5. 5.2 Global Pharmaceuticals Plant Protein Sales by Application
  6. 5.2.1 Global Pharmaceuticals Plant Protein Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceuticals Plant Protein Sales by Application (2021-2032)
  8. 5.2.3 Global Pharmaceuticals Plant Protein Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pharmaceuticals Plant Protein Revenue by Application
  10. 5.3.1 Global Pharmaceuticals Plant Protein Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pharmaceuticals Plant Protein Revenue by Application (2021-2032)
  12. 5.3.3 Global Pharmaceuticals Plant Protein Revenue Market Share by Application (2021-2032)
6 Global Pharmaceuticals Plant Protein Sales by Region
  1. 6.1 Global Pharmaceuticals Plant Protein Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceuticals Plant Protein Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceuticals Plant Protein Sales by Region (2021-2026)
  4. 6.2.2 Global Pharmaceuticals Plant Protein Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceuticals Plant Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pharmaceuticals Plant Protein Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pharmaceuticals Plant Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pharmaceuticals Plant Protein Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pharmaceuticals Plant Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pharmaceuticals Plant Protein Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pharmaceuticals Plant Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pharmaceuticals Plant Protein Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pharmaceuticals Plant Protein Revenue by Region
  1. 7.1 Global Pharmaceuticals Plant Protein Revenue by Region
  2. 7.1.1 Global Pharmaceuticals Plant Protein Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pharmaceuticals Plant Protein Revenue by Region (2021-2026)
  4. 7.1.3 Global Pharmaceuticals Plant Protein Revenue by Region (2027-2032)
  5. 7.1.4 Global Pharmaceuticals Plant Protein Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pharmaceuticals Plant Protein Revenue (2021-2032)
  8. 7.2.2 North America Pharmaceuticals Plant Protein Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pharmaceuticals Plant Protein Revenue (2021-2032)
  11. 7.3.2 Europe Pharmaceuticals Plant Protein Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pharmaceuticals Plant Protein Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pharmaceuticals Plant Protein Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pharmaceuticals Plant Protein Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pharmaceuticals Plant Protein Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ADM
  2. 8.1.1 ADM Company Information
  3. 8.1.2 ADM Business Overview
  4. 8.1.3 ADM Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ADM Pharmaceuticals Plant Protein Product Portfolio
  6. 8.1.5 ADM Recent Developments
  7. 8.2 Cargill
  8. 8.2.1 Cargill Company Information
  9. 8.2.2 Cargill Business Overview
  10. 8.2.3 Cargill Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cargill Pharmaceuticals Plant Protein Product Portfolio
  12. 8.2.5 Cargill Recent Developments
  13. 8.3 DuPont
  14. 8.3.1 DuPont Company Information
  15. 8.3.2 DuPont Business Overview
  16. 8.3.3 DuPont Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 DuPont Pharmaceuticals Plant Protein Product Portfolio
  18. 8.3.5 DuPont Recent Developments
  19. 8.4 Kerry Group
  20. 8.4.1 Kerry Group Company Information
  21. 8.4.2 Kerry Group Business Overview
  22. 8.4.3 Kerry Group Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kerry Group Pharmaceuticals Plant Protein Product Portfolio
  24. 8.4.5 Kerry Group Recent Developments
  25. 8.5 Manildra
  26. 8.5.1 Manildra Company Information
  27. 8.5.2 Manildra Business Overview
  28. 8.5.3 Manildra Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Manildra Pharmaceuticals Plant Protein Product Portfolio
  30. 8.5.5 Manildra Recent Developments
  31. 8.6 Roquette
  32. 8.6.1 Roquette Company Information
  33. 8.6.2 Roquette Business Overview
  34. 8.6.3 Roquette Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Roquette Pharmaceuticals Plant Protein Product Portfolio
  36. 8.6.5 Roquette Recent Developments
  37. 8.7 Tereos
  38. 8.7.1 Tereos Company Information
  39. 8.7.2 Tereos Business Overview
  40. 8.7.3 Tereos Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Tereos Pharmaceuticals Plant Protein Product Portfolio
  42. 8.7.5 Tereos Recent Developments
  43. 8.8 Axiom Foods
  44. 8.8.1 Axiom Foods Company Information
  45. 8.8.2 Axiom Foods Business Overview
  46. 8.8.3 Axiom Foods Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Axiom Foods Pharmaceuticals Plant Protein Product Portfolio
  48. 8.8.5 Axiom Foods Recent Developments
  49. 8.9 Cosucra
  50. 8.9.1 Cosucra Company Information
  51. 8.9.2 Cosucra Business Overview
  52. 8.9.3 Cosucra Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cosucra Pharmaceuticals Plant Protein Product Portfolio
  54. 8.9.5 Cosucra Recent Developments
  55. 8.10 CHS
  56. 8.10.1 CHS Company Information
  57. 8.10.2 CHS Business Overview
  58. 8.10.3 CHS Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CHS Pharmaceuticals Plant Protein Product Portfolio
  60. 8.10.5 CHS Recent Developments
  61. 8.11 Glanbia Nutritionals
  62. 8.11.1 Glanbia Nutritionals Company Information
  63. 8.11.2 Glanbia Nutritionals Business Overview
  64. 8.11.3 Glanbia Nutritionals Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Glanbia Nutritionals Pharmaceuticals Plant Protein Product Portfolio
  66. 8.11.5 Glanbia Nutritionals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceuticals Plant Protein Value Chain Analysis
  2. 9.1.1 Pharmaceuticals Plant Protein Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceuticals Plant Protein Production Mode & Process
  6. 9.2 Pharmaceuticals Plant Protein Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceuticals Plant Protein Distributors
  9. 9.2.3 Pharmaceuticals Plant Protein Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst